Clinical Trials Browser

Phase 2 × Lung Neoplasms × apatinib × Clear all

NCT04425135 2020-06-11

Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC

Phase 2 Unknown

Lung Neoplasms

NCT03411967 2018-01-26

Apatinib in Combination With Docetaxel for Patients With Advanced NSCLC

Phase 2 Unknown

Lung Neoplasms

NCT03135977 2017-12-07

Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line Chemotherapy

Phase 2 Unknown

Lung Neoplasms, Small Cell Lung Carcinoma

NCT02704767 2016-03-10

Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma

Phase 2 Unknown

Lung Neoplasms